Abstract
Background: Suicide is a major public health problem on a global scale, with about 800.000 deaths every year. In particular, it represents one of the main causes of death among adolescents and young adults aged between 15 and 29 years. The World Health Organization (WHO) describes suicide as “an act of deliberate killing” and that is placed at the extreme end of the continuous spectrum of suicidal behaviors (SBs). These include suicidal ideation, attempted suicide and suicide itself.
Objective: The aim of the present review was to better clarify the suicide vulnerability genetic biomarkers and genetic variants correlated with the response to lithium and clozapine and to evaluate some correspondences.
Methods: We reviewed the current literature, focusing our attention on genetic molecular studies about neurobiological systems involved in SBs and pharmacogenetic studies about antisuicidal drugs (lithium and clozapine).
Results: The studies that we have reviewed have shown mixed results. Interestingly, rs1800532 polymorphism of the SLC6A4 gene, encoding for the serotonin transporter, is potentially correlated with both suicide vulnerability and a poor response to lithium and clozapine.
Conclusion: Due to the impact of suicide on public health, more studies are needed to open a promising route to prevent suicide in personalized and precise psychiatry.
Keywords: Suicide, genes, genetic polymorphisms, neurobiological systems, lithium, clozapine.
Current Pharmaceutical Design
Title:Suicide and Genetic Biomarkers: Toward Personalized Tailored-treatment with Lithium and Clozapine
Volume: 27 Issue: 30
Author(s): Domenico De Berardis*, Federica Vellante, Mauro Pettorruso, Lorenza Lucidi, Antonio Tambelli, Ilenia Di Muzio, Giulia Gianfelice, Antonio Ventriglio, Michele Fornaro, Gianluca Serafini, Maurizio Pompili, Giampaolo Perna, Silvia Fraticelli, Giovanni Martinotti and Massimo di Giannantonio
Affiliation:
- National Health Service, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, 'G. Mazzini' Hospital, Piazza Italia 1, 64100 Teramo,Italy
Keywords: Suicide, genes, genetic polymorphisms, neurobiological systems, lithium, clozapine.
Abstract:
Background: Suicide is a major public health problem on a global scale, with about 800.000 deaths every year. In particular, it represents one of the main causes of death among adolescents and young adults aged between 15 and 29 years. The World Health Organization (WHO) describes suicide as “an act of deliberate killing” and that is placed at the extreme end of the continuous spectrum of suicidal behaviors (SBs). These include suicidal ideation, attempted suicide and suicide itself.
Objective: The aim of the present review was to better clarify the suicide vulnerability genetic biomarkers and genetic variants correlated with the response to lithium and clozapine and to evaluate some correspondences.
Methods: We reviewed the current literature, focusing our attention on genetic molecular studies about neurobiological systems involved in SBs and pharmacogenetic studies about antisuicidal drugs (lithium and clozapine).
Results: The studies that we have reviewed have shown mixed results. Interestingly, rs1800532 polymorphism of the SLC6A4 gene, encoding for the serotonin transporter, is potentially correlated with both suicide vulnerability and a poor response to lithium and clozapine.
Conclusion: Due to the impact of suicide on public health, more studies are needed to open a promising route to prevent suicide in personalized and precise psychiatry.
Export Options
About this article
Cite this article as:
De Berardis Domenico *, Vellante Federica , Pettorruso Mauro , Lucidi Lorenza, Tambelli Antonio, Di Muzio Ilenia , Gianfelice Giulia , Ventriglio Antonio , Fornaro Michele , Serafini Gianluca, Pompili Maurizio , Perna Giampaolo, Fraticelli Silvia, Martinotti Giovanni and di Giannantonio Massimo, Suicide and Genetic Biomarkers: Toward Personalized Tailored-treatment with Lithium and Clozapine, Current Pharmaceutical Design 2021; 27 (30) . https://dx.doi.org/10.2174/1381612827666210603143353
DOI https://dx.doi.org/10.2174/1381612827666210603143353 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anesthesia Issues in Central Nervous System Disorders
Current Aging Science The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery
Current Cancer Drug Targets Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part II: Medical Treatment - Study Results
Current Cardiology Reviews Augmentation Strategies to Improve Treatment of Major Depression
Central Nervous System Agents in Medicinal Chemistry Long-Term Outcome of Cardio Respiratory Exercise Performance After Surgery
Current Respiratory Medicine Reviews Principles, Challenges and Advances in ab initio Protein Structure Prediction
Protein & Peptide Letters The Adult Patient with Eisenmenger Syndrome: A Medical Update After Dana Point Part I: Epidemiology, Clinical Aspects and Diagnostic Options
Current Cardiology Reviews Acute Kidney Injury in Pediatric Heart Failure
Current Cardiology Reviews Recent Applications of Replica-Exchange Molecular Dynamics Simulations of Biomolecules
Current Physical Chemistry Targeted Therapies in Patients with Pulmonary Arterial Hypertension Due to Congenital Heart Disease
Current Vascular Pharmacology The Role of a Human Hematopoietic Mesenchymal Progenitor in Wound Healing and Fibrotic Diseases and Implications for Therapy
Current Stem Cell Research & Therapy Bosentan in Pediatric Patients with Pulmonary Arterial Hypertension
Current Vascular Pharmacology Chest Pain in Children
Current Pediatric Reviews The Right Ventricle in Pulmonary Arterial Hypertension: An Organ at the “Heart of the Problem”
Current Respiratory Medicine Reviews Conformational Sampling Techniques
Current Pharmaceutical Design Pulmonary Arterial Hypertension (PAH) Group 1 (Part A): Overview, Classification, Clinical Subsets, and Workup
Current Respiratory Medicine Reviews Radiation and Gene Therapy: Rays of Hope for the New Millennium?
Current Gene Therapy Pulmonary Arterial Hypertension in HIV-infected Patients
Current Hypertension Reviews Genetics and Personalized Medicine in Antidepressant Treatment
Current Pharmaceutical Design